The American Medical Association (AMA) announced an editorial update to Current Procedural Terminology (CPT), that includes a new laboratory test code for the orthopoxvirus and two codes for the vaccines being utilized to prevent monkeypox infection.
New Codes For COVID-19 Novavax Vaccine, Adjuvanted
The U.S. Food and Drug Administration (FDA) authorized emergency use of the Novavax COVID-19 vaccine, Adjuvanted for the prevention of COVID-19 disease in patients 18 years and older. The U.S. Centers for Medicare & Medicaid Services (CMS) issued 3 new Current Procedural Terminology (CPT) codes effective June 13, 2022.
New Codes For Moderna Vaccines For Children 6 Months Through 17 Years
The U.S. Food and Drug Administration (FDA) amended the Moderna COVID-19 vaccine emergency use authorization to authorize use for all patients 6 months through 17 years of age. The U.S. Centers for Medicare & Medicaid Services (CMS) issued 7 new Current Procedural Terminology (CPT) codes effective June 17, 2022.
Use ICD-10 Code U09.9 For Long COVID
For a post COVID-19 condition, unspecified, like Long COVID, use code DX U09.9. Add other codes for conditions related to the COVID-19 infection, like R50.9 for fever.
2023 E/M Code Descriptors & Guidelines Summary Of Revisions
After implementing the 2020 Medicare Physician Fee Schedule Final Rule provision, which included revisions to the Evaluation and Management (E/M) office visit Current Procedural Terminology (CPT) (99201-99215) code descriptors and documentation standards that directly addressed the continuing problem of administrative burden for physicians in nearly every specialty, from across the country, the CPT Editorial Panel approved, for 2023, additional revisions to the rest of the E/M code section. Here’s a summary of revisions:
